Literature DB >> 8393137

E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins.

D A Taylor1, V B Kraus, J J Schwarz, E N Olson, W E Kraus.   

Abstract

The observation that adenovirus E1A gene products can inhibit differentiation of skeletal myocytes suggested that E1A may interfere with the activity of myogenic basic helix-loop-helix (bHLH) transcription factors. We have examined the ability of E1A to mediate repression of the muscle-specific creatine kinase (MCK) gene. Both the E1A12S and E1A13S products repressed MCK transcription in a concentration-dependent fashion. In contrast, amino-terminal deletion mutants (d2-36 and d15-35) of E1A12S were defective for repression. E1A12S also repressed expression of a promoter containing a multimer of the MCK high-affinity E box (the consensus site for myogenic bHLH protein binding) that was dependent, in C3H10T1/2 cells, on coexpression of a myogenin bHLH-VP16 fusion protein. A series of coprecipitation experiments with glutathione S-transferase fusion and in vitro-translated proteins demonstrated that E1A12S, but not amino-terminal E1A deletion mutants, could bind to full-length myogenin and E12 and to deletion mutants of myogenin and E12 that spare the bHLH domains. Thus, the bHLH domains of myogenin and E12, and the high-affinity E box, are targets for E1A-mediated repression of the MCK enhancer, and domains of E1A required for repression of muscle-specific gene transcription also mediate binding to bHLH proteins. We conclude that E1A mediates repression of muscle-specific gene transcription through its amino-terminal domain and propose that this may involve a direct physical interaction between E1A and the bHLH region of myogenic determination proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393137      PMCID: PMC360097          DOI: 10.1128/mcb.13.8.4714-4727.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  Inefficient homooligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding.

Authors:  T Chakraborty; T J Brennan; L Li; D Edmondson; E N Olson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

2.  Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis.

Authors:  T J Brennan; T Chakraborty; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes.

Authors:  P Raychaudhuri; S Bagchi; S H Devoto; V B Kraus; E Moran; J R Nevins
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

4.  Cultivation in vitro of cells derived from a human rhabdomyosarcoma.

Authors:  R M McAllister; J Melnyk; J Z Finkelstein; E C Adams; M B Gardner
Journal:  Cancer       Date:  1969-09       Impact factor: 6.860

5.  Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products.

Authors:  B Zerler; R J Roberts; M B Mathews; E Moran
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

6.  Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer.

Authors:  M S German; M A Blanar; C Nelson; L G Moss; W J Rutter
Journal:  Mol Endocrinol       Date:  1991-02

7.  Repression of insulin gene expression by adenovirus type 5 E1a proteins.

Authors:  R W Stein; E B Ziff
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

8.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

9.  Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product.

Authors:  A Giordano; C McCall; P Whyte; B R Franza
Journal:  Oncogene       Date:  1991-03       Impact factor: 9.867

10.  Repression of the immunoglobulin heavy chain enhancer by the adenovirus-2 E1A products.

Authors:  R Hen; E Borrelli; P Chambon
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

View more
  21 in total

1.  Muscle-regulated expression and determinants for neuromuscular junctional localization of the mouse RIalpha regulatory subunit of cAMP-dependent protein kinase.

Authors:  S Barradeau; T Imaizumi-Scherrer; M C Weiss; D M Faust
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Suppression of E1A-mediated transformation by the p50E4F transcription factor.

Authors:  E R Fernandes; R J Rooney
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  The N terminus of adenovirus type 12 E1A inhibits major histocompatibility complex class I expression by preventing phosphorylation of NF-kappaB p65 Ser276 through direct binding.

Authors:  Junfang Jiao; Hancheng Guan; Andrew M Lippa; Robert P Ricciardi
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 4.  Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes.

Authors:  Peter Pelka; Jailal N G Ablack; Gregory J Fonseca; Ahmed F Yousef; Joe S Mymryk
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

5.  A cellular repressor of E1A-stimulated genes that inhibits activation by E2F.

Authors:  E Veal; M Eisenstein; Z H Tseng; G Gill
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

6.  A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.

Authors:  A Sandmöller; H Meents; H H Arnold
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  Suppression of adenovirus E1A-induced apoptosis by mutated p53 is overcome by coexpression with Id proteins.

Authors:  T Nakajima; M Yageta; K Shiotsu; K Morita; M Suzuki; Y Tomooka; K Oda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  E1A represses apolipoprotein AI enhancer activity in liver cells through a pRb- and CBP-independent pathway.

Authors:  E J Kilbourne; M J Evans; S K Karathanasis
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

9.  The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist.

Authors:  Y Hamamori; H Y Wu; V Sartorelli; L Kedes
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

10.  The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter.

Authors:  J L Meier; X Luo; M Sawadogo; S E Straus
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.